These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34980633)

  • 1. Antibiotic prescribing rate after optimal near-patient C-reactive protein testing in acutely ill children presenting to ambulatory care (ARON project): protocol for a cluster-randomized pragmatic trial.
    Verbakel JYJ; De Burghgraeve T; Van den Bruel A; Coenen S; Anthierens S; Joly L; Laenen A; Luyten J; De Sutter A
    BMJ Open; 2022 Jan; 12(1):e058912. PubMed ID: 34980633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care CRP matters: normal CRP levels reduce immediate antibiotic prescribing for acutely ill children in primary care: a cluster randomized controlled trial.
    Lemiengre MB; Verbakel JY; Colman R; Van Roy K; De Burghgraeve T; Buntinx F; Aertgeerts B; De Baets F; De Sutter A
    Scand J Prim Health Care; 2018 Dec; 36(4):423-436. PubMed ID: 30354904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of C-reactive protein point of care testing to improve antibiotic targeting in respiratory illness in Vietnamese primary care (ICAT): a study protocol for a cluster randomised controlled trial.
    Thi Thuy Do N; Greer RC; Lubell Y; Dittrich S; Vandendorpe M; Nguyen VA; Ngoc Thach P; Thi Dieu Ngan T; Van Kinh N; Hung Thai C; Dung LTK; Nguyen Thi Cam T; Nguyen TH; Nadjm B; van Doorn HR; Lewycka S
    BMJ Open; 2020 Dec; 10(12):e040977. PubMed ID: 33361164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing antibiotic prescribing for acutely ill children in primary care (ERNIE2 study protocol, part B): a cluster randomized, factorial controlled trial evaluating the effect of a point-of-care C-reactive protein test and a brief intervention combined with written safety net advice.
    Lemiengre MB; Verbakel JY; De Burghgraeve T; Aertgeerts B; De Baets F; Buntinx F; De Sutter A;
    BMC Pediatr; 2014 Oct; 14():246. PubMed ID: 25277543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C reactive protein-guided prescription of antibiotics for children under 12 years with respiratory symptoms in Kyrgyzstan: protocol for a randomised controlled clinical trial with 14 days follow-up.
    Isaeva E; Bloch J; Poulsen A; Kurtzhals J; Reventlow S; Siersma V; Akylbekov A; Sooronbaev T; Munck Aabenhus R; Kjærgaard J
    BMJ Open; 2023 Apr; 13(4):e066806. PubMed ID: 37041063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
    Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis.
    Verbakel JY; Lee JJ; Goyder C; Tan PS; Ananthakumar T; Turner PJ; Hayward G; Van den Bruel A
    BMJ Open; 2019 Feb; 9(1):e025036. PubMed ID: 30782747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions.
    Lemiengre MB; Verbakel JY; Colman R; De Burghgraeve T; Buntinx F; Aertgeerts B; De Baets F; De Sutter A
    Br J Gen Pract; 2018 Mar; 68(668):e204-e210. PubMed ID: 29440016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for an 'efficient design' cluster randomised controlled trial to evaluate a complex intervention to improve antibiotic prescribing for CHIldren presenting to primary care with acute COugh and respiratory tract infection: the CHICO study.
    Seume P; Bevan S; Young G; Ingram J; Clement C; Cabral C; Lucas PJ; Beech E; Taylor J; Horwood J; Dixon P; Gulliford MC; Francis N; Creavin ST; Lane A; Hay AD; Blair PS
    BMJ Open; 2021 Mar; 11(3):e041769. PubMed ID: 33782018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial.
    Boere TM; van Buul LW; Hopstaken RM; van Tulder MW; Twisk JWMR; Verheij TJM; Hertogh CMPM
    BMJ; 2021 Sep; 374():n2198. PubMed ID: 34548288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of educational training and C-reactive protein point-of-care testing on antibiotic prescribing in rural and urban family physician practices in Latvia: a randomised controlled intervention study.
    Likopa Z; Kivite-Urtane A; Silina V; Pavare J
    BMC Pediatr; 2022 Sep; 22(1):556. PubMed ID: 36127630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
    Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
    BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial.
    Althaus T; Greer RC; Swe MMM; Cohen J; Tun NN; Heaton J; Nedsuwan S; Intralawan D; Sumpradit N; Dittrich S; Doran Z; Waithira N; Thu HM; Win H; Thaipadungpanit J; Srilohasin P; Mukaka M; Smit PW; Charoenboon EN; Haenssgen MJ; Wangrangsimakul T; Blacksell S; Limmathurotsakul D; Day N; Smithuis F; Lubell Y
    Lancet Glob Health; 2019 Jan; 7(1):e119-e131. PubMed ID: 30554748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care.
    Van den Bruel A; Jones C; Thompson M; Mant D
    Arch Dis Child; 2016 Apr; 101(4):382-5. PubMed ID: 26757989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of point-of-care testing of C-reactive protein concentrations to improve antibiotic targeting in respiratory illness in Vietnamese primary care: a pragmatic cluster-randomised controlled trial.
    Do NTT; Vu TVD; Greer RC; Dittrich S; Vandendorpe M; Pham NT; Ta DN; Cao HT; Khuong TV; Le TBT; Duong TH; Nguyen TH; Cai NTH; Nguyen TQT; Trinh ST; van Doorn HR; Lubell Y; Lewycka S
    Lancet Infect Dis; 2023 Sep; 23(9):1085-1094. PubMed ID: 37230105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost-effectiveness of Improving clinicians' diagnostic and communication Skills on Antibiotic prescribing Appropriateness in patients with acute Cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial.
    Ruiz R; Moragas A; Trapero-Bertran M; Sisó A; Berenguera A; Oliva G; Borràs-Santos A; García-Sangenís A; Puig-Junoy J; Cots JM; Morros R; Mora T; Lanau-Roig A; Monfà R; Troncoso A; Abellana RM; Gálvez P; Medina-Perucha L; Bjerrum L; Amo I; Barragán N; Llor C
    Trials; 2019 Dec; 20(1):740. PubMed ID: 31847912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using point-of-care C-reactive protein to guide antibiotic prescribing for lower respiratory tract infections in elderly nursing home residents (UPCARE): study design of a cluster randomized controlled trial.
    Boere TM; van Buul LW; Hopstaken RM; Veenhuizen RB; van Tulder MW; Cals JWL; Verheij TJM; Hertogh CMPM
    BMC Health Serv Res; 2020 Feb; 20(1):149. PubMed ID: 32103747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing serious infections in acutely ill children in ambulatory care (ERNIE 2 study protocol, part A): diagnostic accuracy of a clinical decision tree and added value of a point-of-care C-reactive protein test and oxygen saturation.
    Verbakel JY; Lemiengre MB; De Burghgraeve T; De Sutter A; Bullens DM; Aertgeerts B; Buntinx F;
    BMC Pediatr; 2014 Oct; 14():207. PubMed ID: 25277457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.